<unk>  is indicated to decrease the need for red blood cell transfusion due to hemolysis (red blood cell destruction) in adults with cold agglutinin disease (CAD).
Sutimlimab
Donanemab
Tafasitamab
Lepra 
Naxitamab
Sargramostim
Tebentafusp
Titermax